000 | 01944 a2200469 4500 | ||
---|---|---|---|
005 | 20250514034755.0 | ||
264 | 0 | _c20020906 | |
008 | 200209s 0 0 eng d | ||
022 | _a0954-691X | ||
024 | 7 |
_a10.1097/00042737-200206000-00010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMulder, C J J | |
245 | 0 | 0 |
_aA double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. _h[electronic resource] |
260 |
_bEuropean journal of gastroenterology & hepatology _cJun 2002 |
||
300 |
_a649-56 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aEsophagitis, Peptic _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLansoprazole |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
650 | 0 | 4 | _aPantoprazole |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 | _aProton Pump Inhibitors |
650 | 0 | 4 |
_aSulfoxides _xadministration & dosage |
700 | 1 | _aWesterveld, B D | |
700 | 1 | _aSmit, J M | |
700 | 1 | _aOudkerk Pool, M | |
700 | 1 | _aOtten, M H | |
700 | 1 | _aTan, T G | |
700 | 1 | _avan Milligen de Wit, A W M | |
700 | 1 | _ade Groot, G H | |
773 | 0 |
_tEuropean journal of gastroenterology & hepatology _gvol. 14 _gno. 6 _gp. 649-56 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042737-200206000-00010 _zAvailable from publisher's website |
999 |
_c11967655 _d11967655 |